Description

TB-500 10 mg Research Product

TB-500 10 mg is supplied as a lyophilized research compound in a clear 3 mL vial. It is identified by compound name and quantity for legitimate laboratory, analytical, and scientific research applications.

TB-500 is commonly described as the acetylated 17–23 fragment of thymosin beta-4. Thymosin beta-4 is a naturally occurring peptide that has been studied in connection with cell migration, angiogenesis, tissue response, inflammation, and repair-related biological pathways. Much of this evidence involves full-length thymosin beta-4 rather than the shorter TB-500 fragment, so findings involving the two should not be treated as interchangeable.

Laboratory and preclinical findings do not establish regulatory approval, safety, effectiveness, or suitability for personal use. A recent medical review noted that rigorous human safety data remain scarce for unapproved peptides such as TB-500.

TB-500 10 mg Product Details

• Compound: TB-500
• Related name: Thymosin beta-4 fragment, LKKTETQ
• Quantity: 10 mg
• Form: Lyophilized research material
• Vial capacity: 3 mL
• SKU: IL-TB500-10
• Storage: Follow the storage information supplied with the applicable product or batch documentation
• Documentation: Batch-specific documentation may be provided when available

Product appearance, packaging, and documentation may vary slightly by batch. Review the applicable label and available documentation before beginning laboratory or analytical work.

TB-500 Research and Product Standards

Infinite Longevity provides clear product identification and available documentation without presenting laboratory or animal findings as guaranteed outcomes.

Research involving full-length thymosin beta-4 has included laboratory studies, animal models, and limited human trials. TB-500 itself is a shorter thymosin beta-4 fragment, and evidence involving the full-length peptide does not automatically establish the behavior, safety, or effectiveness of the fragment.

To better understand certificates of analysis, identity testing, purity results, and the limitations of laboratory documentation, visit the Infinite Longevity Learning Center.

For questions about product availability, orders, shipping, or available documentation, please contact Infinite Longevity.

For regulatory information, review the FDA’s page on bulk drug substances that may present significant safety risks. The FDA identifies TB-500 as thymosin beta-4 fragment LKKTETQ and notes concerns involving aggregation, peptide-related impurities, potential immunogenicity, and the lack of identified human-exposure data for drug products containing this fragment.

Important Research-Use Notice

TB-500 10 mg is intended solely for legitimate laboratory, analytical, and scientific research. It is not intended for human or animal use.

Infinite Longevity does not provide medical advice, dosing information, reconstitution instructions, administration guidance, treatment recommendations, or individualized product protocols.

Purchasers are responsible for understanding the research-use designation, maintaining appropriate laboratory procedures, and complying with all applicable laws, regulations, and institutional requirements.